eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | granulomatosis with polyangiitis |
| Comorbidity | C0023418|leukemia |
| Sentences | 1 |
| PubMedID- 24600203 | Rituximab (rituxan®, genentech, inc.) is a cd20-directed cytolytic antibody indicated for the treatment of non-hodgkin’s lymphoma, chronic lymphocytic leukemia, ra, granulomatosis with polyangiitis (formerly wegener’s granulomatosis), and microscopic polyangiitis. |
Page: 1